Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.947 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9114 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8954 |
High Similarity |
NPD4380 |
Phase 2 |
0.8924 |
High Similarity |
NPD6959 |
Discontinued |
0.891 |
High Similarity |
NPD7768 |
Phase 2 |
0.8896 |
High Similarity |
NPD7411 |
Suspended |
0.8874 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8782 |
High Similarity |
NPD7819 |
Suspended |
0.8734 |
High Similarity |
NPD7075 |
Discontinued |
0.8725 |
High Similarity |
NPD1549 |
Phase 2 |
0.8658 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD1510 |
Phase 2 |
0.8627 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD1240 |
Approved |
0.8485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8415 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8385 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8253 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD1934 |
Approved |
0.825 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8146 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8121 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8098 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8023 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8023 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8011 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7987 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.795 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7907 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7871 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7866 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7849 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7834 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7826 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7806 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7763 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7634 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7634 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7622 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD2798 |
Approved |
0.761 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7607 |
Intermediate Similarity |
NPD920 |
Approved |
0.7605 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7581 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7581 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7581 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7557 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7514 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD943 |
Approved |
0.743 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7389 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.734 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7277 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD919 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7243 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7243 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7198 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7176 |
Intermediate Similarity |
NPD37 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7168 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7151 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7124 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7108 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7076 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7065 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7063
|
Intermediate Similarity |
NPD6355 |
Discontinued |